COVID-19揭示了维尔乔的血栓形成定律
Hubert Daisley1,2, Oneka Acco3, Martina Daisley4
1General Hospital, Department of Pathology, San Fernando, Trinidad and Tobago.
Autopsy & case reports
|October 7, 2024
概括
在 COVID-19 疫情中,
科学领域:
- 肺血管疾病是肺血管疾病.
- 血栓形成的原因之一是血栓形成.
- 病毒病原发生的病毒病原体.
背景情况:
- 维尔霍的定律描述了血栓形成的触发因素:血管壁损伤,血流停滞和高凝血能力.
- COVID-19 与增加的血栓事件有关.
研究的目的:
- 为了调查COVID-19中肺血栓形成的机制.
- 为了确定SARS-CoV-2感染是否会导致肺血管壁内的血栓形成.
主要方法:
- 假定SARS-CoV-2感染了II型膜细胞或细胞周细胞.
- 检查了炎症和内皮细胞相互作用的级联.
- 在肺血管中观察到血栓的位置.
主要成果:
- SARS-CoV-2 感染/受伤促进炎症和内皮细胞相互作用.
- 在肺血管壁内观察到血栓形成.
- 血栓形成并没有发生在血管循环的光线中.
结论:
- 由于COVID-19引起的肺血栓形成,其起源于血管壁.
- SARS-CoV-2 感染启动了一连串导致室内血管血栓形成的过程.
更多相关视频
相关概念视频
Venous Thrombosis I: Introduction
3
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
3
Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Clot Retraction and Fibrinolysis
4.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.7K
Disorders of Hemostasis
738
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
738
Extrinsic and Intrinsic Pathways of Hemostasis
6.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.3K


